Advertisement.

Jim Woods

share

Jim Woods discusses the recent announcement that Senator Kamala Harris will be former Vice President Joe Biden’s running mate in the upcoming presidential election.

share

* (Note: this is the first article in a series of three about pharmaceutical exchange-traded funds (ETFs) * The pharmaceutical industry is one with two prongs. There are the small, risky companies that let investors can gamble on purchasing in hopes they can find a buyer, while there also are the giants doing the buying […]

share

Want to achieve more in life? Of course, you do. The fact that you read this publication basically tells me just that. Yet for most of us, the idea of achieving more comes with the corollary notion that we are going to have to do a lot more, put in more hours, work harder and […]

share

I don’t know about you, but I’ve had just about enough of Big Government telling me what to do. Stay six feet apart, no assemblies of more than 10, 20, 50 people, shelter in place, or whatever the latest restriction on our freedoms are to “save us” from coronavirus. Meanwhile, millions of people have lost […]

share

(Note: fourth in a series on European-focused ETFs) For investors interested in gaining exposure to stocks in the developed economies of Europe, the Vanguard FTSE Europe ETF (NYSE: VGK) may be a fund well worth considering. VGK holds a diverse and comprehensive portfolio of stocks from developed European countries. This fund is unique because, in […]

[European Central Bank]
share

(Note: Third in a series on Europe-focused ETFs) During times of market tumult, many investors choose to purchase shares in companies that have a history of stable dividend growth to secure reliable dividend payouts. Studies by Ned David Research, among others, have lent empirical support to this strategy as scholars have found that both domestic […]